Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hebbar

Showing results (51-60 of 75) with videos related to

Pageof 8
Sort By:
Journal of Chemotherapy (Florence, Italy)|January 12, 2012
FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot studyC Ferte, O Romano, C Mariette, et al.
Surgical Endoscopy|June 21, 2011
Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched studyS Truant, A F Bouras, M Hebbar, et al.
The International Journal of Biological Markers|July 5, 2003
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patientsM Hebbar, M A Krzewinski-Recchi, L Hornez, et al.
La Revue De Medecine Interne|November 14, 2002
[Psychiatric complications of corticoid therapy in the elderly over 65 years of age treated for Horton disease]A L Fauchais, V Boivin, E Hachulla, et al.
Oncology|July 16, 2005
A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinomaEric François, M Hebbar, J Bennouna, et al.
Molecular Cell Biology Research Communications : MCBRC|February 23, 2000
Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7J P Peyrat, M A Recchi, M Hebbar, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancerM Hebbar, J Bonneterre, C Fournier, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 2, 2017
Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysisC Baldini, A Escande, O Bouché, et al.
La Revue De Medecine Interne|August 5, 2000
[A rugbyman and four bats]V Queyrel, U Michon-Pasturel, X Leroy, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
Pageof 8

Showing results (51-60 of 75) with videos related to

Sort By:
Pageof 8
Journal of Chemotherapy (Florence, Italy)|January 12, 2012
FOLFIRI chemotherapy in patients with advanced non resectable esophageal or junctional adenocarcinoma: a pilot studyC Ferte, O Romano, C Mariette, et al.
Surgical Endoscopy|June 21, 2011
Laparoscopic resection vs. open liver resection for peripheral hepatocellular carcinoma in patients with chronic liver disease: a case-matched studyS Truant, A F Bouras, M Hebbar, et al.
The International Journal of Biological Markers|July 5, 2003
Prognostic value of tumoral sialyltransferase expression and circulating E-selectin concentrations in node-negative breast cancer patientsM Hebbar, M A Krzewinski-Recchi, L Hornez, et al.
La Revue De Medecine Interne|November 14, 2002
[Psychiatric complications of corticoid therapy in the elderly over 65 years of age treated for Horton disease]A L Fauchais, V Boivin, E Hachulla, et al.
Oncology|July 16, 2005
A phase II trial of raltitrexed (Tomudex) in advanced pancreatic and biliary carcinomaEric François, M Hebbar, J Bennouna, et al.
Molecular Cell Biology Research Communications : MCBRC|February 23, 2000
Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7J P Peyrat, M A Recchi, M Hebbar, et al.
The Journal of Infusional Chemotherapy|January 1, 1995
Randomized trial comparing conventional intravenous bolus FEC and FEC with high-dose infusional 5-fluorouracil as first-line treatment of advanced breast cancerM Hebbar, J Bonneterre, C Fournier, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|January 2, 2017
Safety and efficacy of FOLFIRINOX in elderly patients with metastatic or locally advanced pancreatic adenocarcinoma: A retrospective analysisC Baldini, A Escande, O Bouché, et al.
La Revue De Medecine Interne|August 5, 2000
[A rugbyman and four bats]V Queyrel, U Michon-Pasturel, X Leroy, et al.
Oncology|March 2, 2011
Cost-minimisation analysis in first-line treatment of metastatic colorectal cancer in France: XELOX versus FOLFOX-6G Perrocheau, J Bennouna, M Ducreux, et al.
Pageof 8